Skip to content

Contact +44 (0) 20 7060 7474 email us

Supplements

Vitamins and Dietary Supplements in Demark

 

Publication Date November 2007
Publisher Euromonitor International
Product Type Report
Pages 31
ISBN Number not applicable
Product Code EUR00915

Price

£450.00
approximately: $681 | €502

pdf immediate delivery

Buy Now

Order above formats by FAX

Order by Fax

Summary

Euromonitor International's Vitamins and Dietary Supplements in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: vitamins, dietary supplements, tonics and bottled nutritive drinks, child-specific vitamins and dietary supplements Data coverage: market sizes (historic and forecasts), company shares and brand shares.

Why buy this report?

  • Get a detailed picture of the vitamins and dietary supplements industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

  • Executive Summary
  • Health Standards Remain Low but Improve
    • Nrt Smoking Cessation Aids Dynamic but from Low Base
    • Fragmented Sales LED by Multinationals
    • Consumers Prefer Specialised Distribution Outlets
    • Faster Growth in Forecast Period
  • Key Trends and Developments
    • Growing State Funding Supports Increased Sales
    • Rx Medicines Still Dominate
    • Competition from Homeopathy Intensifies
    • Counterfeiting Still Huge but Losing Appeal
    • Rising Foreign Investment Results in More Consolidated Shares
    • Chained Chemists/Pharmacies Increasingly Significant
  • City Key Trends and Developments
    • Moscow
    • St Petersburg
  • Market Indicators
  • Market Data
  • Appendix
    • Otc Registration and Classification
    • De-Listing or De-Reimbursement
    • Advertising
    • Packaging and Labelling
    • Distribution
    • Vitamins and Dietary Supplements Registration and Classification
    • Generics
    • Consumer Expenditure on Health Goods and Medical Services
    • Definitions
    • Sources
  • Local Company Profiles - Russia
    • Akrikhin Oao - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Evalar Zao - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Krka Pharma Ooo - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Naturprodukt Europe Bv - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Nizhpharm Ao - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Otechestvennye Lekarstva Group - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Pharmstandard Group - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Ranbaxy Laboratories Ltd - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
    • Veropharm Zao - Otc Healthcare - Russia
      • Strategic Direction
      • Key Facts
      • Company Background
      • Production
      • Competitive Positioning
      • Analgesics in Russia
      • Headlines
      • Trends
      • Competitive Landscape
      • Prospects
      • Sector Data
  • List of Summaries
    • Summary 1 Research Sources
    • Summary 2 Akrikhin Oao: Key Facts
    • Summary 3 Akrikhin Oao: Operational Indicators 2004-2006
    • Summary 4 Akrikhin Oao: Competitive Position 2006
    • Summary 5 Evalar Zao: Key Facts
    • Summary 6 Evalar Zao: Operational Indicators
    • Summary 7 Evalar Zao: Production Statistics 2006
    • Summary 8 Evalar Zao: Competitive Position 2006
    • Summary 9 Krka Pharma Ooo: Key Facts
    • Summary 10 Krka Dd/ Krka Pharma Ooo: Operational Indicators 2006
    • Summary 11 Krka Pharma Ooo: Competitive Position 2006
    • Summary 12 Naturprodukt Europe Bv: Key Facts
    • Summary 13 Naturprodukt Europe Bv: Operational Indicators 2004-2005
    • Summary 14 Naturprodukt Europe Bv: Competitive Position 2006
    • Summary 15 Nizhpharm Oao: Key Facts
    • Summary 16 Nizhpharm Oao: Operational Indicators 2004-2006
    • Summary 17 Nizhpharm Oao: Competitive Position 2006
    • Summary 18 Otechestvennye Lekarstva Group: Key Facts
    • Summary 19 Otechestvennye Lekarstva Group: Operational Indicators 2005-2006
    • Summary 20 Schelkovsky Vitaminy Zavod: Competitive Position 2006
    • Summary 21 Novosibkhimpharm Aoot: Competitive Position 2006
    • Summary 22 Pharmstandard Group: Key Facts
    • Summary 23 Pharmstandard Group: Operational Indicators 2004-2006
    • Summary 24 Pharmstandard Group: Production Statistics 2006
    • Summary 25 Pharmstandard Group: Competitive Position 2006
    • Summary 26 Ranbaxy Laboratories Limited: Key Facts
    • Summary 27 Ranbaxy Laboratories Limited: Operational Indicators 2004-2006
    • Summary 28 Ranbaxy Laboratories Ltd: Competitive Position 2006
    • Summary 29 Veropharm Zao: Key Facts
    • Summary 30 Veropharm Zao: Operational Indicators 2004-2006
    • Summary 31 Veropharm Zao: Production Statistics 2006
    • Summary 32 Veropharm Zao: Competitive Position 2006
  • List of Tables
    • Table 1 Life Expectancy at Birth 2001-2006
    • Table 2 Sales of Otc Healthcare by Sector: Value 2001-2006
    • Table 3 Sales of Otc Healthcare by Sector: % Value Growth 2001-2006
    • Table 4 Sales of Otc Healthcare by City: Value 2001-2006
    • Table 5 Sales of Otc Healthcare by City: % Value Growth 2001-2006
    • Table 6 Otc Healthcare Company Shares by Retail Value 2002-2006
    • Table 7 Otc Healthcare Brand Shares by Retail Value 2003-2006
    • Table 8 Sales of Otc Healthcare by Distribution Format: % Analysis 2001/2006
    • Table 9 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2006
    • Table 10 Forecast Sales of Otc Healthcare by Sector: Value 2006-2011
    • Table 11 Forecast Sales of Otc Healthcare by Sector: % Value Growth 2006-2011
    • Table 12 Forecast Sales of Otc Healthcare by City: Value 2006-2011
    • Table 13 Forecast Sales of Otc Healthcare by City: % Value Growth 2006-2011
    • Table 14 Consumer Expenditure on Health Goods and Medical Services 2001-2006
    • Table 15 Sales of Analgesics by Subsector: Value 2001-2006
    • Table 16 Sales of Analgesics by Subsector: % Value Growth 2001-2006
    • Table 17 Herbal vs Standard Topical Analgesics 2001/2006
    • Table 18 Analgesics Company Shares by Retail Value 2002-2006
    • Table 19 Analgesics Brand Shares by Retail Value 2003-2006
    • Table 20 Forecast Sales of Analgesics by Subsector: Value 2006-2011
    • Table 21 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011